Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

NCT07159360 · MarsiBionics · Updated 8 Sept 2025

What is being tested
CLINICAL EXPLORER
For
Neuromuscular Disorders; Neurodevelopmental Disorders
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 2 years to 17 years. About 60 people. The full rules are on the registry page.
Where
Mexico, Spain (2 sites)
When
Starts or started 15 Sept 2025, ends 1 June 2026. Registered 8 Sept 2025.
Results
None posted yet.

In the researchers' words

Neurodevelopmental disorders often result in abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as the inability to stand and walk. CLINICAL EXPLORER is a clinical-use robotic device for gait training, representing the evolution of the ATLAS 2030 exoskeleton and the EXPLORER device for home use. The aim of this study is to evaluate the safety and usability of CLINICAL EXPLORER .
ClinicalTrials.gov, NCT07159360

Sites

  • Asociación Pro Personas con Paralisis Cerebral (APAC-IAP)Mexico City, Mexico City, Mexico
  • Hospital Infantil Universitario Niño Jesús-Servicio de Neuro OrtopediaMadrid, Madrid, Spain